title: Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis.
authors.forename: A M
authors.initials: AM
authors.lastname: Vicari
authors.forename: F
authors.initials: F
authors.lastname: Ciceri
authors.forename: F
authors.initials: F
authors.lastname: Folli
authors.forename: R
authors.initials: R
authors.lastname: Lanzi
authors.forename: B
authors.initials: B
authors.lastname: Colombo
authors.forename: G
authors.initials: G
authors.lastname: Comi
authors.forename: L
authors.initials: L
authors.lastname: Camba
mesh_terms: D000328:Adult; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000139:chemically induced*; D008297:Male; D008942:Mitoxantrone / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D059005:Topoisomerase II Inhibitors
chemical_list: D059005:Topoisomerase II Inhibitors; D008942:Mitoxantrone